Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Abbreviated MRI could become standard of care for prostate cancer diagnosis
Biparametric prostate MRIs take significantly less time than multiparametric exams, as they do not include a contrast-enhanced sequence. This also makes the abbreviated exams more cost-friendly.
Late-stage prostate cancer diagnoses on the rise
Experts say these new findings highlight the need for more effective screening initiatives among men who may face access barriers.
Surgeons can 'hear' cancerous lesions with help of new dual-mode radiotracer
When used during surgery, it can help providers identify cancerous lesions that are not in their immediate vision.
Shine working toward U.S. production of Mo-99 for SPECT imaging
Greg Piefer, PhD, chief executive and founder of SHINE, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first U.S. commercial supplier of molybdenum-99 in decades.
New radioummonotherapy may be more effective at treating ovarian cancer than current standard of care
The method targets cancer stem cells, which are highly tumorigenic and known to play a significant role in relapse, cancer spread and treatment resistance.

Advanced PET/MRI protocols boost lung cancer detection

Experts involved in the new research indicate that PET/MRI could have an increasingly prevalent role in lung cancer staging and restaging.

A 'clear lack of adherence' in imaging guidelines is impacting lung cancer survival rates

A study published in the January issue of the Journal of Nuclear Medicine reveals that nearly half of Medicare patients with NSCLC in the United States do not complete recommended FDG PET/CT scans prior to treatment.

#glioblastoma multiforme #GBM #braintumor

Deep learning helps experts take advantage of 'rare' chance to study deadly tumor progression

Researchers from the University of Waterloo and the University of Toronto are collaborating to better understand how glioblastoma multiforme (GBM) advances when it is not treated.

AI tool predicts lung cancer without radiologists or clinical histories

The deep learning model was trained to predict risk of lung cancer in the one to six years following completion of an LDCT scan, and it does not require clinical information relative to risk factors to do so.

New data on DCIS surveillance imaging has experts concerned

A concerning number of women do not follow through with recommended surveillance imaging following treatment for breast cancer.

Takeshi Tsuda, MD, pediatric cardiologist, Nemours Children’s Health, Delaware, discusses evaluation of cardio-toxicity in pediatric cancer patients. He presented a study at American Heart Association (AHA) 2022 meeting that hoped to show the use of cardiac stress testing on children would indicate which patients would see more toxicity from chemotherapy agents. #AHA #AHA22

VIDEO: Identifying cardiotoxicity in young cancer patients

Pediatric cardiologist Takeshi Tsuda, MD, discussed the evaluation of cardiotoxicity in young cancer patients at the American Heart Association (AHA) 2022 meeting.

Woman dies of lung cancer after radiologist fails to recommend follow-up for ‘large’ abnormality

According to reports, the respiratory physician who treated the patient following her lung cancer diagnosis described her death as “totally avoidable."

New radiotracer IDs numerous cancers likely to respond to targeted therapy

The radiotracer, 68Ga-PentixaFor, can be used for detecting C-X-C motif chemokine receptor 4 (CXCR4), which plays a significant role in cancer progression.

Oncology Imaging

Abbreviated MRI could become standard of care for prostate cancer diagnosis

Late-stage prostate cancer diagnoses on the rise

Surgeons can 'hear' cancerous lesions with help of new dual-mode radiotracer

Shine working toward U.S. production of Mo-99 for SPECT imaging

New radioummonotherapy may be more effective at treating ovarian cancer than current standard of care